We have previously shown that treatment with SAMe and betaine potentiates IFNα signaling and enhances the anti-viral efficacy of IFNα in osteosarcoma cells expressing HCV proteins and in human hepatoma Huh7 cells harboring an HCV replicon [13]. This evidence concerns the gene IFNA1 and osteosarcoma.